Brii Biosciences

Brii Biosciences

Phase 3
Durham, United StatesFounded 2018briibio.com

We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insi...

Founded
2018
Focus
AntibodiesBiologicsSmall Molecules

About

We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insi...

Funding History

2

Total raised: $455M

Series C$300MTemasek HoldingsJan 15, 2022
Series B$155MHillhouse CapitalMar 15, 2021

Company Info

TypePrivate
Founded2018
LocationDurham, United States
StagePhase 3
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile